NCT00850174View on ClinicalTrials.gov

Oxcarbazepine 600 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Healthy
Interventions
DRUG

Oxcarbazepine

600 mg Tablet

DRUG

Trileptal®

600 mg Tablet

Trial Locations (1)

M1R 5A3

Pharma Medica Research Inc., Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00850174 - Oxcarbazepine 600 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter